[헬스코리아뉴스] SK chemical, a domestic drug maker is carrying forward the acquisition of OSSTEM implant.
An official of SK chemical said on 15 Jan 2010 that it was considering the acquisition of OSSTEM implant, an implant service management company. But he added that any final decision was not yet made.
This acquisition will help SK chemical's growth power in the furture.
On same day, shares of OSSTEM implant rose 1,850 won, to 14,450 won on the news of the acquisition.